RM-493

setmelanotide · Rhythm Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RM-493, covering 2015-05-01 to 2023-08-14. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Study to Evaluate Safety and Efficacy of RM-493 in Obese Participants [Phase 2]